Literature DB >> 10777508

p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism.

O D Lau1, A D Courtney, A Vassilev, L A Marzilli, R J Cotter, Y Nakatani, P A Cole.   

Abstract

p300/CBP-associated factor (PCAF) is a histone acetyltransferase that plays an important role in the remodeling of chromatin and the regulation of gene expression. It has been shown to catalyze preferentially acetylation of the epsilon-amino group of lysine 14 in histone H3. In this study, the kinetic mechanism of PCAF was evaluated with a 20-amino acid peptide substrate derived from the amino terminus of histone H3 (H3-20) and recombinant bacterially expressed PCAF catalytic domain (PCAF(cat)). The enzymologic behavior of full-length PCAF and PCAF(cat) were shown to be similar. PCAF-catalyzed acetylation of the substrate H3-20 was shown to be specific for Lys-14, analogous to its behavior with the full-length histone H3 protein. Two-substrate kinetic analysis displayed an intersecting line pattern, consistent with a ternary complex mechanism for PCAF. The dead-end inhibitor analog desulfo-CoA was competitive versus acetyl-CoA and noncompetitive versus H3-20. The dead-end analog inhibitor H3-20 K14A was competitive versus H3-20 and uncompetitive versus acetyl-CoA. The potent bisubstrate analog inhibitor H3-CoA-20 was competitive versus acetyl-CoA and noncompetitive versus H3-20. Taken together, these inhibition patterns support an ordered BiBi kinetic mechanism for PCAF in which acetyl-CoA binding precedes H3-20 binding. Viscosity experiments suggest that diffusional release of product is not rate-determining for PCAF catalysis. These results provide a mechanistic framework for understanding the detailed catalytic behavior of an important subset of the histone acetyltransferases and have significant implications for molecular regulation of and inhibitor design for these enzymes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777508     DOI: 10.1074/jbc.M003219200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.

Authors:  Erin M Bowers; Gai Yan; Chandrani Mukherjee; Andrew Orry; Ling Wang; Marc A Holbert; Nicholas T Crump; Catherine A Hazzalin; Glen Liszczak; Hua Yuan; Cecilia Larocca; S Adrian Saldanha; Ruben Abagyan; Yan Sun; David J Meyers; Ronen Marmorstein; Louis C Mahadevan; Rhoda M Alani; Philip A Cole
Journal:  Chem Biol       Date:  2010-05-28

2.  Histone H3-K56 acetylation is catalyzed by histone chaperone-dependent complexes.

Authors:  Toshiaki Tsubota; Christopher E Berndsen; Judith A Erkmann; Corey L Smith; Lanhao Yang; Michael A Freitas; John M Denu; Paul D Kaufman
Journal:  Mol Cell       Date:  2007-02-22       Impact factor: 17.970

3.  Catalytic mechanism of a MYST family histone acetyltransferase.

Authors:  Christopher E Berndsen; Brittany N Albaugh; Song Tan; John M Denu
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

4.  Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.

Authors:  Fabien Guidez; Louise Howell; Mark Isalan; Marek Cebrat; Rhoda M Alani; Sarah Ivins; Itsaso Hormaeche; Melanie J McConnell; Sarah Pierce; Philip A Cole; Jonathan Licht; Arthur Zelent
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  A new coactivator function for Zac1's C2H2 zinc finger DNA-binding domain in selectively controlling PCAF activity.

Authors:  Anke Hoffmann; Dietmar Spengler
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

Review 6.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

Review 7.  Chemical probes for histone-modifying enzymes.

Authors:  Philip A Cole
Journal:  Nat Chem Biol       Date:  2008-10       Impact factor: 15.040

8.  Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription.

Authors:  V Swaminathan; A Hari Kishore; K K Febitha; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Inhibition of histone acetyltransferase by glycosaminoglycans.

Authors:  Jo Ann Buczek-Thomas; Edward Hsia; Celeste B Rich; Judith A Foster; Matthew A Nugent
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

Review 10.  Catalysis and substrate selection by histone/protein lysine acetyltransferases.

Authors:  Christopher E Berndsen; John M Denu
Journal:  Curr Opin Struct Biol       Date:  2008-12       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.